跳至主要内容
临床试验/NCT01271257
NCT01271257已完成1 期

Phase 1 Study of Titrated Oral Misoprostol

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
AUC480 (the area under the curve of serum concentration of misoprostol acid against time up to 480 minutes)

研究概览

简要总结

The AUC240, AUC360, and AUC480 of titrated oral misoprostol are greater than traditional oral misoprostol.

详细描述

The primary outcomes measures of the study are the area under the curve of serum concentration of misoprostol acid against time up to 240, 360 and 480 minutes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 20-40 Y/O healthy and non-pregnant woman

排除标准

  • heart, liver or kidney disease, anaphylaxis to misoprostol

研究组 & 干预措施

hourly misoprostol

Experimental

20 microgram misoprostol intake per hour

干预措施: Misoprostol (Drug)

traditional misoprostol

Active Comparator

80 microgram misoprostol intake per 4 hours

干预措施: Misoprostol (Drug)

结局指标

主要结局

AUC480 (the area under the curve of serum concentration of misoprostol acid against time up to 480 minutes)

时间窗: 480 min post start of oral misoprostol administration

次要结局

  • AUC360 (the area under the curve of serum concentration of misoprostol acid against time up to 360 minutes)(360 min post start of oral misoprostol administration)
  • AUC240 (the area under the curve of serum concentration of misoprostol acid against time up to 240 minutes)(240 min post start of oral misoprostol administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shi-Yann Cheng

Director of Department of Obstetrics and Gynecology

China Medical University Hospital

研究点 (1)

Loading locations...

相似试验

Pharmacokinetics of Misoprostol With Titrated Oral... | 临床试验